step 1 trial semaglutide 2.4 mg weight loss nejm 2021 Phase 3 of in Metabolic Dysfunction–Associated Steatohepatitis Chronic Weight Management Trial Results

FLOW (A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease) was a Phase 3b kidney outcomes trial enrolling 3,533 adults with type 2 diabetes and CKD

The ratio of GSH to GSSG is a direct indicator of cellular redox status, and when that ratio shifts, it signals oxidative stress

E., Pasternak, B., Eliasson, B

Here's the Part Most People Don't Know: Your GLP-1 Response Is Unique to You Two people can eat the exact same meal same calories, same carbs, same everything and have completely different blood sugar curves, different hunger responses, and different energy levels afterwards

Stimulant laxatives (senna, bisacodyl, cascara) trigger colonic contractions to push stool along